Search J Rheum

Advanced Search

Home

Current Issue

Archives

Guidelines for Authors

Classified Ads

Subscriptions

Contact Info

E-mail Alert Service

Links

Case Report

Catastrophic Antiphospholipid Syndrome: Clinical Description and Triggering Factors in 8 Patients

JORGE ROJAS-RODRIGUEZ, MARIO GARCIA-CARRASCO, MANUEL RAMOS-CASALS, GUILLERMO ENRIQUEZ-CORONEL, CARLOS COLCHERO, RICARD CERVERA, and JOSEP FONT

  ABSTRACT.

In 1992, an attempt to single out a different and important group of patients was adopted by introducing the term “catastrophic” antiphospholipid syndrome (APS) to describe their potentially life threatening clinical course, characterized by acute multiorgan failure (3 or more organ systems damaged). Patients previously described in the literature showed certain differences that appear to distinguish this minority group of patients with catastrophic APS from the majority of APS patients. We describe 8 patients with catastrophic APS, focusing especially on the possible extrinsic factors (mainly infections) that might trigger this “catastrophic” situation. (J Rheumatol 2000;27:238–40)

  Key Indexing Terms:
ANTIPHOSPHOLIPID SYNDROME
ANTIPHOSPHOLIPID ANTIBODIES
SYSTEMIC LUPUS ERYTHEMATOSUS



Return to January 2000 Table of Contents



© 2000. The Journal of Rheumatology Publishing Company Limited.
All rights reserved.